Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Healthy: early-phase trial registry
225 of 1,096 indexed Healthy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2 of 28,707 conditions by registered trial count.
1,096 US clinical trials · 225 currently recruiting · #2 of 28,707 conditions by registered trial count
Healthy: 1,096 US clinical trials tracked, 225 recruiting.
Healthy is the subject of 1,096 registered US clinical trials on ClinicalTrials.gov, 225 of them currently open to new participants. 43 are in Phase 3-4 (later-stage) and 546 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 55 of these trials.
Enrollment posture brief
Registry condition healthy
OPEN 225 | RECR 21% | LATE 43 | EARLY 546 | RANK #2 | SPON 55
Volume-matched condition peers
Nearest open-share peer: Psoriasis (20% recruiting · 127 trials)
Healthy lists 225 open slots (21% of 1,096 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Healthy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Healthy is recruiting below its size-band peers.
225 of 1,096 indexed trials (20.5%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Healthy trials is spread across many organizations.
Eli Lilly and Company accounts for 55 of 1,096 trials (5%). 429 distinct sponsors appear on at least one study for this condition label.
-
Most Healthy trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 1,091 trials that report a genuine target (sentinel values excluded). 851 of those (78%) plan for fewer than 100 participants.
-
Healthy research is mostly interventional.
905 interventional and 191 observational studies make up this index (82.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
1,096 total, page 9 of 22
Screening Herbs for Drug Interactions
National Center for Complementary and Integrative Health (NCCIH)
NCT00029263
Evaluation of Cow Milk-Based Formulas - Functional Proteins
Mead Johnson Nutrition
NCT00916565
Cigarette Smoke and Susceptibility to Influenza Infection
University of North Carolina, Chapel Hill
NCT00448617
Muscle Mass and Nutritional Risk in Older Adults
University of Florida
NCT03566758
A Study of LY3540378 in Healthy Participants
Eli Lilly and Company
NCT04768855
Beta-glucan, Product Claims and Satiety
General Mills
NCT04740112
Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents
Aegerion Pharmaceuticals
NCT00359281
Lens Wearing Experience and Biocompatibility of a Multi-Purpose Disinfecting Solution (MPDS)
Alcon Research
NCT01476722
Effects of MIB-626 With and Without A High-Intensity Multi-Dimensional Exercise Training Program
Metro International Biotech
NCT05878119
Study to Assess the Pharmacokinetic and Pharmacodynamic Bioequivalence of CHS-1701 With Neulasta
Coherus Oncology
NCT02650973
High-density EEG in Neurological Disorders
Dartmouth-Hitchcock Medical Center
NCT04266041
A Randomized Phase 1 of of MZE001 in Healthy Volunteers
Maze Therapeutics
NCT05249621
Effects of Plant Concentrate Blend on Oxidative Stress in Healthy Humans
Access Business Group
NCT02213588
Transcranial Magnetic Stimulation (TMS) Studies of Dystonia
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00017875
Body Composition in Infants and Children
Arkansas Children's Hospital Research Institute
NCT00921817
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
Neurogastrx
NCT06500429
A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults
Pfizer
NCT06106009
Examining the Longitudinal Relationship Between Sleep and Weight Gain in College Students
Oakland University
NCT04100967
Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability
Ardea Biosciences
NCT02581553
Tolerance and Development of Healthy, Term Infants
Abbott Nutrition
NCT00465764
A Study of Imlunestrant (LY3484356) in Female Healthy Participants
Eli Lilly and Company
NCT05444556
RTA 408 Lotion in Healthy Volunteers
Biogen
NCT02029716
Interhemispheric Plasticity in Humans
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00120666
Behavioral Differences in Effortful Control
University of Michigan
NCT01852344
Racial Differences in Control of Blood Vessel Tone and Blood Flow
National Heart, Lung, and Blood Institute (NHLBI)
NCT00001747
Safety and Tolerability of SYNB1934 in Healthy Adult Volunteers
Synlogic
NCT04984525
A Study of Single and Repeated Doses of LY3556050 in Healthy Participants
Eli Lilly and Company
NCT05341102
NC Thermometer (Gen 3) ISO 80601-2-56 Validation
Natural Cycles
NCT05721131
Brain Function in Mentally Ill Adolescents
National Institute of Mental Health (NIMH)
NCT00025857
Immune and Hormone Response to Influenza Vaccine
Johns Hopkins Bloomberg School of Public Health
NCT01978262
Bioequivalence of Duvelisib and Food Effect on Pharmacokinetics of IPI-145
SecuraBio
NCT02307461
Study to Assess the Bioequivalence of Ibrutinib 560- Milligram (mg) Tablet to Four 140 -mg IMBRUVICA Capsules
Janssen Research & Development
NCT02841150
Bioequivalence Study of Abiraterone Acetate Coated and Uncoated Tablet Formulations in Healthy Male Participants
Janssen Research & Development
NCT02230046
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Ad26.ZIKV.001 in Healthy Adult Volunteers
Janssen Vaccines & Prevention B.V.
NCT03356561
Analysis of the Mechanisms of Protective Humoral Immunity in Response to the Pneumococcal Vaccine
Mayo Clinic
NCT00589394
Variation In Facial Morphology As A Determinant Of Face Covering Performance: FACEFIT
University of North Carolina, Chapel Hill
NCT05388201
A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's Syndrome
Biogen
NCT02422407
Oropharynx (OPX) Salivary Biomarker Study
Mayo Clinic
NCT05093400
Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed Patients
National Institute of Mental Health (NIMH)
NCT00369798
Collection of Anatomical and Reference Data for Development of a Novel Non-Invasive Lung Hydration Status Technology
Intersection Medical
NCT02426593
PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects
Peplin
NCT01302925
Cannabidiol and Focus Study (CBD-Focus)
University of Northern Colorado
NCT05189275
A Study of LC542019 in Healthy Subjects and Subjects With T2DM
LG Chem
NCT06333977
A Study of Ixekizumab in Healthy Participants
Eli Lilly and Company
NCT03848416
Encouraging Cognitive Screenings at African American Churches
University of Kansas Medical Center
NCT05037578
A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers
Pfizer
NCT02265718
Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NCT00014027
A Study of JNJ-68179280 in Healthy Participants
Janssen Research & Development
NCT04844463
Racial and Aging Effects of Acute Antioxidant Supplementation
University of Illinois at Chicago
NCT02157207
Pharmacokinetics of Oral Mirabegron With Different Release Rates Versus Intravenous (IV) Mirabegron
Astellas Pharma
NCT00940121
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 518 |
| Phase 2 | 28 |
| Phase 3 | 11 |
| Phase 4 | 32 |
Top Sponsors
Named interventions
Most-linked intervention names on Healthy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Healthy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Healthy page
1,096 registered trials, 225 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 225 Healthy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Eli Lilly and Company sponsors the most Healthy trials on record, review their full trial history before evaluating a specific study. See Eli Lilly and Company's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Healthy condition card totals 1,096 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.